Cover Image

Selective 5-HT<sub>6</sub> Receptor Ligands (Agonist and Antagonist) Show Different Effects on Antipsychotic Drug-Induced Metabolic Dysfunctions in Rats

It is estimated that in patients taking antipsychotic drugs (APDs), metabolic syndrome occurs 2-3 times more often than in the general population. It manifests itself in abdominal obesity, elevated glucose concentration, and dyslipidemia. Despite the high prevalence of this disorder, only a small pe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anna Partyka (Author), Katarzyna Górecka (Author), Joanna Gdula-Argasińska (Author), Natalia Wilczyńska-Zawal (Author), Magdalena Jastrzębska-Więsek (Author), Anna Wesołowska (Author)
Format:	Book
Published:	MDPI AG, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetics of DA-6886, A New 5-HT<sub>4</sub> Receptor Agonist, in Rats
by: Dae Young Lee, et al.
Published: (2022)

Novel <i>N</i>-Arylsulfonylindoles Targeted as Ligands of the 5-HT<sub>6</sub> Receptor. Insights on the Influence of C-5 Substitution on Ligand Affinity
by: Loreto Arrieta-Rodríguez, et al.
Published: (2021)

Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT<sub>1A</sub> Serotonin Receptor Antagonists
by: Kinga Ostrowska, et al.
Published: (2021)

Impact of 5-HT<sub>3</sub> receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study
by: Lin Swu-Jane, et al.
Published: (2012)

Effects of the DL76 Antagonist/Inverse Agonist of Histamine H<sub>3</sub> Receptors on Experimental Periodontitis in Rats: Morphological Studies
by: Mariusz Geremek, et al.
Published: (2024)

Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT<sub>1A</sub> Receptor Biased Agonist
by: Sharon Cabanu, et al.
Published: (2022)

Dual Targeting Ligands-Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo Evaluation
by: Dorota Łażewska, et al.
Published: (2022)

An agonist sensitive, quick and simple cell-based signaling assay for determination of ligands mimicking prostaglandin E<sub>2 </sub>or E<sub>1 </sub>activity through subtype EP<sub>1 </sub>receptor: Suitable for high throughput screening
by: Ruan Ke-He, et al.
Published: (2011)

Monitoring of tacrolimus concentration after kidney or heart transplantation - the importance of intra-subject variability parameters
by: Agnieszka Małgorzata Cios, et al.
Published: (2022)

Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent Manner
by: Nina Wolska, et al.
Published: (2020)

Substituted Purines as High-Affinity Histamine H<sub>3</sub> Receptor Ligands
by: Christian Espinosa-Bustos, et al.
Published: (2022)

Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor
by: Habib Abul Muntasir, et al.
Published: (2006)

Synthesis and Pharmacological Characterization of New Photocaged Agonists for Histamine H<sub>3</sub> and H<sub>4</sub> Receptors
by: Yang Zheng, et al.
Published: (2024)

Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A<sub>1</sub> and A<sub>3</sub> Adenosine Receptors
by: Luke J. Hamilton, et al.
Published: (2023)

Effects of (−)‐MBP, a novel 5‐HT2C agonist and 5‐HT2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice
by: Preeti K. Sathe, et al.
Published: (2023)

Tumor Immunotherapy Using A<sub>2A</sub> Adenosine Receptor Antagonists
by: Jinfeng Zhang, et al.
Published: (2020)

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022)

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT<sub>1A</sub> and D<sub>2</sub> Receptors
by: Kinga Sałaciak, et al.
Published: (2021)

A simple open source bioinformatic methodology for initial exploration of GPCR ligands' agonistic/antagonistic properties
by: Athanasios A. Panagiotopoulos, et al.
Published: (2020)

Is the anxiolytic-like effect of acute 8-0H-DPAT mediated by 5-HT<sub>1A</sub> receptors?
by: Elisabeth Aparecida Audi, et al.
Published: (2008)

Combined Antagonism of 5-HT<sub>2</sub> and NMDA Receptors Reduces the Aggression of Monoamine Oxidase a Knockout Mice
by: Roberto Frau, et al.
Published: (2022)

Species Differences in Microsomal Metabolism of Xanthine-Derived A<sub>1</sub> Adenosine Receptor Ligands
by: Daniela Schneider, et al.
Published: (2021)

Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT<sub>1 </sub>receptor signaling
by: Hurley Joyce H, et al.
Published: (2008)

First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H<sub>3</sub>R Ligands with Antioxidant Properties
by: Tobias Werner, et al.
Published: (2024)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023)

Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe<sub>3</sub>O<sub>4</sub> Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor
by: Itziar Galarreta-Rodriguez, et al.
Published: (2023)

Guanidines: Synthesis of Novel Histamine H<sub>3</sub>R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect
by: Marek Staszewski, et al.
Published: (2023)

Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M<sub>1</sub> Antagonists
by: Jonas Kilian, et al.
Published: (2022)

Histamine H<sub>3</sub> Receptor Ligands-KSK-59 and KSK-73-Reduce Body Weight Gain in a Rat Model of Excessive Eating
by: Kamil Mika, et al.
Published: (2021)

The Effect of KSK-94, a Dual Histamine H<sub>3</sub> and Sigma-2 Receptor Ligand, on Adipose Tissue in a Rat Model of Developing Obesity
by: Magdalena Kotańska, et al.
Published: (2024)

Activation of Adenosine A<sub>1</sub> Receptor in Ischemic Stroke: Neuroprotection by Tetrahydroxy Stilbene Glycoside as an Agonist
by: Lingyu Ruan, et al.
Published: (2021)

Characterization of Subtype Selective Cannabinoid CB<sub>2</sub> Receptor Agonists as Potential Anti-Inflammatory Agents
by: Yaliang Tang, et al.
Published: (2021)

HBK-10, A Compound with α<sub>1</sub>-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats
by: Klaudia Lustyk, et al.
Published: (2022)

Na<sub>v </sub>1.8-null mice show stimulus-dependent deficits in spinal neuronal activity
by: Wood John N, et al.
Published: (2006)

Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus
by: Motohiro Okada, et al.
Published: (2019)

BMS-986020, a Specific LPA<sub>1</sub> Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
by: Bhakta Prasad Gaire, et al.
Published: (2020)

The Short Lipopeptides (C<sub>10</sub>)<sub>2</sub>-KKKK-NH<sub>2</sub> and (C<sub>12</sub>)<sub>2</sub>-KKKK-NH<sub>2</sub> Protect HaCaT Keratinocytes from Bacterial Damage Caused by <i>Staphylococcus aureus</i> Infection in a Co-Culture Model
by: Kirsten Reddersen, et al.
Published: (2020)

Do AutoML-Based QSAR Models Fulfill OECD Principles for Regulatory Assessment? A 5-HT<sub>1A</sub> Receptor Case
by: Natalia Czub, et al.
Published: (2022)

Rational Design, Synthesis, and Evaluation of Fluorescent CB<sub>2</sub> Receptor Ligands for Live-Cell Imaging: A Comprehensive Review
by: Pinaki Bhattacharjee, et al.
Published: (2023)

Lion's Mane Mushroom, <i>Hericium erinaceus</i> (Bull.: Fr.) Pers. Suppresses H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Damage and LPS-Induced Inflammation in HT22 Hippocampal Neurons and BV2 Microglia
by: Naufal Kushairi, et al.
Published: (2019)